Physical Activity to Improve Patient Reported Outcomes for Adults With Acute Leukemia
Build Stamina
Testing a Nurse-Led Evidence-Based Exercise Program to Improve Patient-Reported Outcomes in Adults With Acute Leukemia
1 other identifier
interventional
49
1 country
2
Brief Summary
The purpose of this study is to test the efficacy of an evidence-based tailored physical activity program adapted for adults with acute leukemia. Implementation-related process evaluation of the physical activity program will also be assessed.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2021
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 4, 2020
CompletedFirst Posted
Study publicly available on registry
September 17, 2020
CompletedStudy Start
First participant enrolled
January 15, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 15, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
September 15, 2022
CompletedSeptember 23, 2022
August 1, 2022
1.7 years
September 4, 2020
September 22, 2022
Conditions
Outcome Measures
Primary Outcomes (2)
Physical Function- Short Physical Performance Battery Protocol
Measured via evaluation on Chair Stand Test (up to 4 points), Gait Speed Test (up to 4 points) and the 4 Test Balance Scale (up to 4 points) scores can range from 0-12 points. Higher scores = better physical function
12-weeks
Physical Function- 6 Minute walk test
The 6 minute walk Test measures an individuals ability to walk in meters for 6 minutes. The distance walk in meters is recorded. Higher meter = better physical function
12-weeks
Secondary Outcomes (5)
Patient-Reported Outcomes- Cognition
12-weeks
Patient-Reported Outcomes-Fatigue
12-weeks
Patient-Reported Outcomes-Disturbed Sleep
12-weeks
Patient-Reported Outcomes-Anxiety
12-weeks
Patient-Reported Outcomes-Depression
12-weeks
Study Arms (2)
Build Stamina Group
EXPERIMENTALThe Build StaMINA (Biobehavioral Self-Management INtervention using physical Activity) is a tailored evidence-based physical activity (PA) program designed to improve endurance, strength, and balance which are all areas of physical function, that adults with acute leukemia (AL) post-induction are known to have diminished capacity. The Build StaMINA program will be tailored to their current Physical Function, per assessment. The detailed PA prescription includes each exercise in the program as well as the frequency, number of repetitions each day and rate of perceived exertion (RPE) for each exercise. The repetitions and RPE are based on the participants' current Physical Function Assessment and will be assigned based on our evidence-based algorithm.
Attention-Control Group
NO INTERVENTIONParticipants assigned to the attention control group will have a Physical Function Assessment at baseline after informed consent has been provided and prior to randomization. Participants will also be asked to complete questionnaires regarding at baseline, 6-weeks and 3 months. Those in the attention-control group will also receive a newsletter detailing the benefits of participating in regular PA as well as regular phone calls by study team to discuss general health and wellbeing at the same schedule as intervention group.
Interventions
Build StaMINA intervention is a self-management intervention that provides information, motivation, behavioral skills to engage in PA, and ultimately a tailored PA program for adults with AL who are receiving consolidation/maintenance chemotherapy.
Eligibility Criteria
You may qualify if:
- \>18 years
- Diagnosed with either acute leukemia
- Receiving either maintenance or consolidation chemotherapy
- Able to walk independently for 4 meters with or without gait aid.
You may not qualify if:
- non-English speaking
- receiving induction chemotherapy.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Duke Universitylead
- Oncology Nursing Societycollaborator
Study Sites (2)
University of North Carolina
Chapel Hill, North Carolina, 27514, United States
Duke University Health System
Durham, North Carolina, 27710, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Tara A Albrecht, PhD, ACNP-BC, ACNP-BC, ACHPN
Duke University School of Nursing
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 4, 2020
First Posted
September 17, 2020
Study Start
January 15, 2021
Primary Completion
September 15, 2022
Study Completion
September 15, 2022
Last Updated
September 23, 2022
Record last verified: 2022-08
Data Sharing
- IPD Sharing
- Will not share